Status: Recruiting
Epcoritamab-CAR T Cells for Large B-cell Lymphomas
This study investigates the feasibility and efficacy of epcoritamab treatment before CAR T cells. This study also investigates if, when patients have residual lymphoma after CAR T cells, epcoritamab can help to effectively treat that lymphoma.
Participants needed: 31
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Abramson Cancer Center at Penn MedicineUpdated: May 27, 2026Locations: 1
Eligibility criteria
Age > 18 years [+11]
Inability or unwillingness of the patient or legally authorized representative (... [+24]